Prime vendor pharm branch-philadelphia
Ended Indefinite Delivery Contract Awarded
- Contract number
- SPE2DX16D9410
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 405 $2,633,415 obligated
Award facts
- Combined order value
- $2,633,415 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 53% used
- $4,999,999.99
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. Through this contract, DMS Pharmaceutical Group provides branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various therapeutic categories such as oncology, contraceptives, and specialty pharmaceuticals. The contract does not have a set-aside designation, enabling DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards. The overall contract has an ultimate completion date of December 31, 2025, with individual delivery orders issued under the IDC having completion dates through 2024 and 2025.
This IDC allows the DLA to procure a wide variety of pharmaceutical items, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and specialized medications like Xolair, Trikafta, Keytruda, Botox, and Nucala. The delivery orders issued under this contract have ceiling values ranging from a few hundred dollars to over $27,000, with the majority being firm fixed-price contracts. This contract award positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.
Task orders
Show 40 more
Latest 50 of 405 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DX16D9410?
SPE2DX16D9410 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on December 17, 2015.
How much is contract SPE2DX16D9410 worth?
Orders under SPE2DX16D9410 have obligated $2,633,415. SPE2DX16D9410's own ceiling is $5,000,000.
How many orders have been placed under contract SPE2DX16D9410?
405 orders have been placed under SPE2DX16D9410, the latest on October 20, 2025.
Who can order from contract SPE2DX16D9410?
SPE2DX16D9410 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DX16D9410 competed?
The extent of competition for SPE2DX16D9410 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV